Anti-cancer drugs
Human Epidermal Growth Factor Receptor-2 positive metastatic salivary duct carcinoma with remarkable response to targeted therapy: a case report and therapeutic implications.
Clara Rodrigo Juan, Carla Climent Vicente, Francisco Xavier Avilés Jurado, Noemí Bartolomé Cerdà, Joan Lop Gros, Manuel Mazariegos Rubi
Published: 202610.1097/CAD.0000000000001814
Abstract
Salivary duct carcinoma (SDC) is a rare and highly aggressive malignancy that frequently overexpresses Human Epidermal Growth Factor Receptor 2 (HER2). Despite the increasing recognition of HER2-targeted strategies, evidence remains limited and large…
Preview only. Read the full abstract at the source